BOSTON, MA – May 11, 2021 – As clinical trial awareness continues to rise across the nation, due in part to conversations around coronavirus vaccines, it has never been more important for the general public to better understand the processes behind and importance of clinical research. Today, the Center for Information and Study on Clinical Research Participation (CISCRP) announced AWARE for All - Northwest, a free virtual event on Thursday, May 20, from 3:30 - 5:00 p.m. PDT, designed to educate residents from the Washington; Oregon; Idaho; Montana; and Northern California areas about clinical trial research and participation.
AWARE for All - Northwest, hosted on a user-friendly digital conference platform, will feature discussions with clinical trial participants and medical professionals who share their personal stories. The event will highlight specific therapeutic areas and medical conditions that affect patients across the Northwest U.S., including multiple sclerosis (neurology), COVID-19 (infectious disease), and cancer (oncology).
AWARE for All - Northwest attendees can expect to:
Michael Louella, outreach coordinator at the University of Washington AIDS Clinical Trials Unit and member of the AWARE for All - Northwest planning team, shared his insights on the importance of the event. Working with the unit for more than 20 years, Louella has witnessed firsthand how research impacts the lives of participants.
“Volunteers in clinical trials are essentially the co-creators of medicine, and the AWARE for All event series helps spread the important role that these participants play,” said Louella. “You can impact your future, and the future of others, by learning more and getting involved in a clinical trial today that’s right for you. Without participation, there is no moving forward”
During the event, attendees will hear from clinical trial participants on their own patient journeys and experiences, including Desiree Deluca-Johnson, a breast cancer trial participant and manager of trial curation and public education for BreastCancerTrials.org. Deluca-Johnson was diagnosed with breast cancer at age 40 and was unaware that cancer centers and clinical research could be a care option for her. After diving into her own research, and finding out more about clinical trials, she eventually found a handful of trials that she would be eligible for.
“Through my active clinical trial education and participation, I had been given access to treatments that I might not have considered before,” said Deluca-Johnson. “Now, I am in a trial to monitor for recurrence, and I can make an action plan for quality of life.”
In addition to facilitated conversations with Deluca-Johnson, attendees can expect to hear from:
“Our AWARE for All - Northwest event will provide participants with an incredible amount of knowledge to better understand the clinical trial process in addition to learning more about potential opportunities that could benefit their own personal conditions – or conditions of friends and loved ones,” said Phyllis Kaplan, senior manager, events and community engagement, CISCRP. “To expand the event series’ footprint, this year, we decided to span across all five U.S. regions to reach as many individuals as possible, focusing on particular therapeutic conditions that hit home in these areas.”